This website uses cookies to enhance the user experience.
||
I

IP EQOLOGY HOLDCO AS818 781 202

Limited company
c/o ImmunoPharma AS Mustads vei 1A 0283 OSLO, Norge

IP EQOLOGY HOLDCO AS

Operating
Investering i andre selskaper, herunder gjennom å erverve aksjer og andeler eller ved å yte lån samt det som naturlig står i forbindelse med dette.

Organization

Chairman of the board
Years since formation
9 years
since Mar 29, 2017
Type
Limited company
VAT registered
No
Number of employees
0

Ownership

Number of shares and share classes
20,000,000
1 share class
Total number of shareholders
1
company
Belongs to group of

Financials

Annual total result 2025
88,853,203
NOK
Total equity 2025
51,846,704
NOK
Last update: Jun 27, 2026

Management

Board

NameRoleShares
Chairman-
Alternate Member-

Others

NameRoleShares
F
FORVIS MAZARS AS
Auditor-

Top 10 individual shareholders

NameRoleShares
-
35.45 %
indirectly
-
23.57 %
indirectly
-
1.6 %
indirectly
-
1.44 %
indirectly
-
1.23 %
indirectly
Last update: Jul 3, 2026

Ownership

Company shareholders

NameShare classTotal number of sharesShare
I
IMMUNOPHARMA AS
Ordinary shares
20,000,000
100 %

Shares owned by the IP EQOLOGY HOLDCO AS

NameShare classTotal number of sharesShare
E
EQOLOGY AS
Closed
Ordinary shares
108,551,350
98.97 %
Last update: Jun 2, 2025

Group structure

  • Total operating income 2025: NOK 18,004,610
    Operating profit 2025: NOK -20,461,195
    Employees: 15

Financials

in NOK

Summary

Year20252024202320222021
Total operating income
0
0
0
0
0
Annual Total Result
88,853,203
94,864,689
65,181,153
380,732
-9,101,806
Total assets
377,601,901
269,417,430
219,357,115
110,954,314
83,117,695
Total liabilities
325,755,196
196,774,156
186,143,601
90,512,258
63,056,371
Total equity
51,846,704
72,643,274
33,213,514
20,442,055
20,061,324

P&L

Year20252024202320222021
Total operating income
0
0
0
0
0
Total operating costs
58,287
68,687
48,219
42,420
38,126
Operating result
-58,287
-68,687
-48,219
-42,420
-38,126
Financial income/costs
119,838,349
110,568,870
80,011,593
423,151
-9,063,680
Profit before tax
119,780,062
110,500,182
79,963,375
380,732
-9,101,806
Total tax & extraordinary income/cost
30,926,859
15,635,493
14,782,222
0
0
Annual Total Result
88,853,203
94,864,689
65,181,153
380,732
-9,101,806

Balance overview

Year20252024202320222021
Total fixed assets
236,573,446
144,541,283
149,350,322
107,583,028
82,991,001
Total current assets
141,028,454
124,876,148
70,006,793
3,371,285
126,694
Total assets
377,601,901
269,417,430
219,357,115
110,954,314
83,117,695
Short term debt
161,378,747
89,626,423
67,192,051
135
63,056,371
Long term debt
164,376,449
107,147,733
118,951,550
90,512,123
0
Total liabilities
325,755,196
196,774,156
186,143,601
90,512,258
63,056,371
Contributed capital
23,811,324
23,811,324
23,811,324
23,811,324
23,811,324
Retained earnings
28,035,380
48,831,950
9,402,190
-3,369,269
-3,750,000
Total equity
51,846,704
72,643,274
33,213,514
20,442,055
20,061,324
Total equity and liabilities
377,601,901
269,417,430
219,357,115
110,954,314
83,117,695

Classification

21st company classification
BETA
Scaleup
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises